+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Felodipine Extended-Release Tablets Market - Global Forecast 2026-2032- Product Image
Felodipine Extended-Release Tablets Market - Global Forecast 2026-2032- Product Image
Sale

Felodipine Extended-Release Tablets Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6142913
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Felodipine Extended-Release Tablets Market is projected to reach USD 1.78 Billion in 2026. It is expected to continue growing at a CAGR of 8.58%, reaching USD 2.94 Billion by 2032.

Felodipine Extended-Release Tablets: Executive Overview

Felodipine extended-release tablets are oral dihydropyridine calcium-channel blockers used to help manage hypertension. Their extended-release formulation is designed for once-daily administration, supporting sustained exposure and routine adherence. Clinical use is shaped by prescribing guidance, patient cardiovascular risk, tolerability, contraindications, and access to appropriately approved products.

Hypertension Care Is Shifting Toward Consistent, Patient-Centered Use

The therapeutic landscape is being reshaped by stronger emphasis on blood-pressure control over the full dosing interval, simplified regimens, and earlier identification of patients at elevated cardiovascular risk. Clinicians must balance blood-pressure reduction with adverse effects such as peripheral edema, flushing, headache, and palpitations, while considering interactions and comorbidities. Medication persistence, reliable supply, generic quality, and integration with home monitoring increasingly influence treatment outcomes.

Artificial Intelligence Strengthens Monitoring and Treatment Support

Artificial intelligence can support hypertension care by identifying patients at risk of poor control, detecting patterns in home blood-pressure readings, and helping clinicians prioritize follow-up. It may also assist medication-reconciliation workflows, adherence interventions, safety-signal review, and supply planning. These applications require validated data, transparent clinical oversight, protection of personal health information, and safeguards against biased recommendations; AI should augment, not replace, prescribing judgment.

Regional Insights: Access and Care Delivery Differ Across Six Major Geographies

North America generally combines established hypertension guidelines with broad use of electronic records, while Latin America continues to face uneven access, affordability constraints, and differences in primary-care capacity. Europe places substantial emphasis on guideline-based cardiovascular prevention and regulatory quality, with variation across national reimbursement systems. The Middle East shows expanding chronic-disease programs alongside differences in specialist and pharmacy access. Africa faces pronounced disparities in diagnosis, continuity of care, and medicine availability. Asia-Pacific includes highly developed health systems as well as rapidly expanding primary-care networks, creating varied needs for affordable, quality-assured extended-release treatment.

Group Insights: Policy Alignment Shapes Hypertension Access

ASEAN markets reflect diverse regulatory systems, reimbursement arrangements, and primary-care capabilities, making harmonized quality standards and dependable distribution important. BRICS members span markedly different disease burdens, procurement structures, and domestic manufacturing environments, favoring context-specific access strategies. The European Union benefits from coordinated regulatory principles but retains national differences in reimbursement and prescribing practice. G7 countries generally have mature clinical infrastructure and strong pharmacovigilance expectations. GCC health systems often combine substantial healthcare investment with high chronic-disease demand. NATO members include diverse health systems, so resilience of pharmaceutical supply and continuity of care remain relevant across the group.

Country Insights: Local Guidelines and Reimbursement Determine Uptake

Australia, Canada, France, Germany, Italy, Japan, South Korea, Spain, the United Kingdom, and the United States have established hypertension-care infrastructures, but prescribing pathways, formularies, generic substitution, and monitoring practices differ. Brazil, China, India, Mexico, and Russia encompass large and heterogeneous populations with varied public-private provision, regional access, and affordability conditions. Across all fifteen countries, product registration, quality assurance, pharmacy availability, clinician familiarity, and patient persistence are central considerations; local guideline alignment and reimbursement status should be assessed before commercial or clinical decisions are made.

Priorities for Leaders: Improve Quality, Continuity, and Evidence-Based Use

Industry leaders should maintain rigorous product quality and pharmacovigilance systems, document formulation performance, and support clear labeling for appropriate once-daily use. They should work with healthcare providers and payers on adherence education, blood-pressure monitoring, and practical switching protocols where clinically appropriate. Supply planning should address regional procurement differences and continuity risks. Evidence generation should focus on real-world persistence, safety in relevant patient groups, and outcomes under routine care, while digital and AI tools should be deployed only with clinical validation, privacy controls, and measurable patient-benefit criteria.

Research Methodology: Structured Review of Clinical, Regulatory, and Access Evidence

This executive summary uses a structured qualitative review framework centered on felodipine extended-release tablets. The assessment considers approved therapeutic use, formulation characteristics, safety and tolerability considerations, hypertension-care developments, regulatory and reimbursement context, healthcare-system differences, and responsible applications of artificial intelligence. Regional, group, and country perspectives are synthesized from established clinical and policy dimensions rather than from market estimates, forecasts, shares, or company-specific claims. Findings should be interpreted alongside current national labeling, treatment guidelines, and local access rules.

Conclusion: Consistent Blood-Pressure Control Depends on Integrated Care

Felodipine extended-release tablets remain relevant within a broader hypertension-management pathway that prioritizes sustained control, tolerability, adherence, and dependable access. The most effective strategies will align product quality with local clinical guidance, strengthen patient monitoring, and address affordability and supply continuity. Carefully governed digital and AI-enabled tools can reinforce these goals when supported by validated evidence, clinician accountability, and strong privacy protections.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Felodipine Extended-Release Tablets Market, by Dosage Strength
7.1. Introduction
7.2. 10 Mg
7.3. 2.5 Mg
7.4. 5 Mg
8. Felodipine Extended-Release Tablets Market, by Packaging
8.1. Introduction
8.2. Blister Packs
8.3. Bottles
9. Felodipine Extended-Release Tablets Market, by Application
9.1. Introduction
9.2. Hypertension
9.3. Stable Angina
10. Felodipine Extended-Release Tablets Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.2.1. Private Hospital Pharmacies
10.2.2. Public Hospital Pharmacies
10.3. Online Pharmacies
10.3.1. Company Owned Website
10.3.2. Third Party Platforms
10.4. Retail Pharmacies
11. Felodipine Extended-Release Tablets Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Homecare Settings
11.4. Hospitals
12. Felodipine Extended-Release Tablets Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Felodipine Extended-Release Tablets Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Felodipine Extended-Release Tablets Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Amneal Pharmaceuticals, Inc.
16.2. AstraZeneca plc
16.3. Aurobindo Pharma Ltd
16.4. Cipla Limited
16.5. Cipla Limited
16.6. Dr. Reddy's Laboratories Limited
16.7. Glenmark Pharmaceuticals Limited
16.8. Lupin Limited
16.9. Novartis AG
16.10. Pfizer Inc.
16.11. Sun Pharmaceutical Industries Limited
16.12. Teva Pharmaceutical Industries Ltd
16.13. Torrent Pharmaceuticals Limited
16.14. Viatris Inc
16.15. Wockhardt Bio Ag
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Felodipine Extended-Release Tablets Market, Years Considered for the Study
FIGURE 2. Global Felodipine Extended-Release Tablets Market, Research Design
FIGURE 3. Global Felodipine Extended-Release Tablets Market, Research Framework
FIGURE 4. Global Felodipine Extended-Release Tablets Market, Data Triangulation
FIGURE 5. Global Felodipine Extended-Release Tablets Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2025 vs 2032 (%)
FIGURE 7. Global Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Felodipine Extended-Release Tablets Market Size, by Packaging, 2025 vs 2032 (%)
FIGURE 9. Global Felodipine Extended-Release Tablets Market Size, by Packaging, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Felodipine Extended-Release Tablets Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Felodipine Extended-Release Tablets Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Felodipine Extended-Release Tablets Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Felodipine Extended-Release Tablets Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Felodipine Extended-Release Tablets Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Felodipine Extended-Release Tablets Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Felodipine Extended-Release Tablets Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Felodipine Extended-Release Tablets Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Felodipine Extended-Release Tablets Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Felodipine Extended-Release Tablets Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Felodipine Extended-Release Tablets Market Segmentation & Coverage
TABLE 2. Global Felodipine Extended-Release Tablets Market Size, 2017-2032 (USD Million)
TABLE 3. Global Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 4. Global 10 Mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global 10 Mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global 10 Mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global 2.5 Mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global 2.5 Mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global 2.5 Mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global 5 Mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global 5 Mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global 5 Mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 14. Global Blister Packs Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Blister Packs Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Blister Packs Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Bottles Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Bottles Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Bottles Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 21. Global Hypertension Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Hypertension Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Hypertension Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Stable Angina Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Stable Angina Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Stable Angina Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 28. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Private Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Private Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Private Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Public Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Public Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Public Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Company Owned Website Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Company Owned Website Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Company Owned Website Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Third Party Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Third Party Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Third Party Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 50. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Homecare Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Homecare Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Homecare Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Felodipine Extended-Release Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Felodipine Extended-Release Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. North America Felodipine Extended-Release Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. North America Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 70. North America Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 71. North America Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 72. North America Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 73. North America Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 74. North America Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 75. North America Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. Latin America Felodipine Extended-Release Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Latin America Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 78. Latin America Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 79. Latin America Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 80. Latin America Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 81. Latin America Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 82. Latin America Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 83. Latin America Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. Europe Felodipine Extended-Release Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Europe Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 86. Europe Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 87. Europe Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. Europe Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 89. Europe Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 90. Europe Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 91. Europe Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Middle East Felodipine Extended-Release Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Middle East Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 94. Middle East Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 95. Middle East Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 96. Middle East Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 97. Middle East Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 98. Middle East Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 99. Middle East Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Africa Felodipine Extended-Release Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Africa Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 102. Africa Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 103. Africa Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. Africa Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 105. Africa Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 106. Africa Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 107. Africa Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Global Felodipine Extended-Release Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. ASEAN Felodipine Extended-Release Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. ASEAN Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 111. ASEAN Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 112. ASEAN Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. ASEAN Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 114. ASEAN Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 115. ASEAN Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 116. ASEAN Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. GCC Felodipine Extended-Release Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. GCC Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 119. GCC Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 120. GCC Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. GCC Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 122. GCC Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 123. GCC Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 124. GCC Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. European Union Felodipine Extended-Release Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. European Union Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 127. European Union Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 128. European Union Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. European Union Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 130. European Union Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 131. European Union Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 132. European Union Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. BRICS Felodipine Extended-Release Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. BRICS Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 135. BRICS Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 136. BRICS Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. BRICS Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 138. BRICS Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 139. BRICS Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 140. BRICS Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. G7 Felodipine Extended-Release Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. G7 Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 143. G7 Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 144. G7 Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. G7 Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. G7 Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 147. G7 Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 148. G7 Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. NATO Felodipine Extended-Release Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. NATO Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 151. NATO Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 152. NATO Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. NATO Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 154. NATO Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 155. NATO Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 156. NATO Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Global Felodipine Extended-Release Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. United States Felodipine Extended-Release Tablets Market Size, 2017-2032 (USD Million)
TABLE 159. United States Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 160. United States Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 161. United States Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. United States Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 163. United States Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 164. United States Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 165. United States Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Canada Felodipine Extended-Release Tablets Market Size, 2017-2032 (USD Million)
TABLE 167. Canada Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 168. Canada Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 169. Canada Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. Canada Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 171. Canada Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 172. Canada Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 173. Canada Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. Mexico Felodipine Extended-Release Tablets Market Size, 2017-2032 (USD Million)
TABLE 175. Mexico Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 176. Mexico Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 177. Mexico Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. Mexico Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 179. Mexico Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 180. Mexico Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 181. Mexico Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. Brazil Felodipine Extended-Release Tablets Market Size, 2017-2032 (USD Million)
TABLE 183. Brazil Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 184. Brazil Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 185. Brazil Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Brazil Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 187. Brazil Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 188. Brazil Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 189. Brazil Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. United Kingdom Felodipine Extended-Release Tablets Market Size, 2017-2032 (USD Million)
TABLE 191. United Kingdom Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 192. United Kingdom Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 193. United Kingdom Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. United Kingdom Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 195. United Kingdom Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 196. United Kingdom Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 197. United Kingdom Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. Germany Felodipine Extended-Release Tablets Market Size, 2017-2032 (USD Million)
TABLE 199. Germany Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 200. Germany Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 201. Germany Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. Germany Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 203. Germany Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 204. Germany Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 205. Germany Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. France Felodipine Extended-Release Tablets Market Size, 2017-2032 (USD Million)
TABLE 207. France Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 208. France Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 209. France Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. France Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 211. France Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 212. France Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 213. France Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Russia Felodipine Extended-Release Tablets Market Size, 2017-2032 (USD Million)
TABLE 215. Russia Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 216. Russia Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 217. Russia Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. Russia Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 219. Russia Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 220. Russia Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 221. Russia Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Italy Felodipine Extended-Release Tablets Market Size, 2017-2032 (USD Million)
TABLE 223. Italy Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 224. Italy Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 225. Italy Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. Italy Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 227. Italy Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 228. Italy Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 229. Italy Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Spain Felodipine Extended-Release Tablets Market Size, 2017-2032 (USD Million)
TABLE 231. Spain Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 232. Spain Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 233. Spain Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. Spain Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 235. Spain Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 236. Spain Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 237. Spain Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. China Felodipine Extended-Release Tablets Market Size, 2017-2032 (USD Million)
TABLE 239. China Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 240. China Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 241. China Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 242. China Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 243. China Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 244. China Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 245. China Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. India Felodipine Extended-Release Tablets Market Size, 2017-2032 (USD Million)
TABLE 247. India Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 248. India Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 249. India Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 250. India Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 251. India Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 252. India Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 253. India Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. Japan Felodipine Extended-Release Tablets Market Size, 2017-2032 (USD Million)
TABLE 255. Japan Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 256. Japan Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 257. Japan Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 258. Japan Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 259. Japan Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 260. Japan Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 261. Japan Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. Australia Felodipine Extended-Release Tablets Market Size, 2017-2032 (USD Million)
TABLE 263. Australia Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 264. Australia Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 265. Australia Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. Australia Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 267. Australia Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 268. Australia Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 269. Australia Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. South Korea Felodipine Extended-Release Tablets Market Size, 2017-2032 (USD Million)
TABLE 271. South Korea Felodipine Extended-Release Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 272. South Korea Felodipine Extended-Release Tablets Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 273. South Korea Felodipine Extended-Release Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. South Korea Felodipine Extended-Release Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 275. South Korea Felodipine Extended-Release Tablets Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 276. South Korea Felodipine Extended-Release Tablets Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 277. South Korea Felodipine Extended-Release Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. Global Felodipine Extended-Release Tablets Market Share, by Key Player, 2025
TABLE 279. Global Felodipine Extended-Release Tablets Market, Key Experts

Companies Mentioned

  • Amneal Pharmaceuticals, Inc.
  • AstraZeneca plc
  • Aurobindo Pharma Ltd
  • Cipla Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories Limited
  • Glenmark Pharmaceuticals Limited
  • Lupin Limited
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd
  • Torrent Pharmaceuticals Limited
  • Viatris Inc
  • Wockhardt Bio Ag

Related Topics

Related Reports

Sitagliptin Metformin Extended Release Tablets Market - Global Forecast 2026-2032 - Product Image

Sitagliptin Metformin Extended Release Tablets Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Terfenadine Tablets Market - Global Forecast 2026-2032 - Product Image

Terfenadine Tablets Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Isosorbide Mononitrate Tablet Market Report 2026 - Product Image

Isosorbide Mononitrate Tablet Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Nebivolol Tablets Market Report 2026 - Product Image

Nebivolol Tablets Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Toilet Bowl Cleaner Tablets Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Image

Toilet Bowl Cleaner Tablets Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.